Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-14

Clinical Trial Update: Silica Gel Fiber Wound Dressing for Chronic Venous Leg Ulcers [Phase 2]

View source ↗

Summary

Phase 2 trial of Silica Gel Fiber Wound Dressing for venous ulcers has been terminated. The sponsor is Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Silica Gel Fiber Wound Dressing

Snippet

Sponsor: Bayer | Conditions: Venous Ulcer | Phase 2 | Status: TERMINATED